Analyzing the impact of pharmacogenomics-guided nonsteroidal anti-inflammatory drug alerts in clinical practice.
This study evaluates response rates of pharmacogenomics (PGx) nonsteroidal anti-inflammatory drugs (NSAIDs) clinical decision support (CDS) alerts at Sanford Health from May 2020 to December 2024.
Author(s): Massmann, Amanda, Petry, Natasha J, Weaver, Max, Brady, Halle, Lupu, Roxana A
DOI: 10.1093/jamiaopen/ooaf112